Products Categories
CAS No.: | 71620-89-8 |
---|---|
Name: | Reboxetine mesylate |
Article Data: | 20 |
Molecular Structure: | |
Formula: | C19H23NO3 |
Molecular Weight: | 313.397 |
Synonyms: | Reboxetine;Reboxitine; |
EINECS: | 1592732-453-0 |
Density: | 1.113 g/cm3 |
Melting Point: | 141-143oC |
Boiling Point: | 443.7 °C at 760 mmHg |
Flash Point: | 188.2 °C |
Appearance: | White Solid |
PSA: | 39.72000 |
LogP: | 3.52260 |
What can I do for you?
Get Best Price
This chemical is called Reboxetine [INN], and its systematic name is (2R)-2-[(R)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine. With the CAS registry number of 71620-89-8, its classification codes are Adrenergic Agents; Adrenergic Uptake Inhibitors; Antidepressive Agents; Central Nervous System Agents; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Psychotropic Drugs. Additionally, its product category is Adrenoceptors.
Other characteristics of the Reboxetine [INN] can be summarised as followings: (1)ACD/LogP: 2.82; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.15; (4)ACD/LogD (pH 7.4): 1.8; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 7.9; (7)ACD/KOC (pH 5.5): 1.73; (8)ACD/KOC (pH 7.4): 78.64; (9)#H bond acceptors: 4; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 6; (12)Polar Surface Area: 30.93 Å2; (13)Index of Refraction: 1.553; (14)Molar Refractivity: 90.13 cm3; (15)Molar Volume: 281.4 cm3; (16)Polarizability: 35.73×10-24cm3; (17)Surface Tension: 41.8 dyne/cm; (18)Density: 1.113 g/cm3; (19)Flash Point: 188.2 °C; (20)Enthalpy of Vaporization: 70.14 kJ/mol; (21)Boiling Point: 443.7 °C at 760 mmHg; (22)Vapour Pressure: 4.54E-08 mmHg at 25°C.
You can still convert the following datas into molecular structure:
1.SMILES: O(c1ccccc1OCC)[C@H](c2ccccc2)[C@@H]3OCCNC3
2.InChI: InChI=1/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1
3.InChIKey: CBQGYUDMJHNJBX-RTBURBONBC
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 457ug/kg/8D-I (0.457mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING | New England Journal of Medicine. Vol. 342, Pg. 215, 2000. Link to PubMed |